RFC4 protects colorectal cancer cells from X-ray-induced DNA damage and apoptosis through nonhomologous end joining (NHEJ)-mediated DNA repair37 and has also been associated with poorer prognosis in this malignancy38 and lung cancer39. Here, RFC4 is linked to medical procedure.